Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
27.09
+0.05 (0.18%)
At close: Mar 9, 2026, 4:00 PM EDT
27.40
+0.31 (1.14%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $252.55 million as of March 9, 2026. Its market cap has increased by 572.85% in one year.
Market Cap
252.55M
Enterprise Value
181.19M
1-Year Change
572.85%
Ranking
Category
Stock Price
$27.09
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $252.55M, an increase of 109.32%. That is a compound annual growth rate of 15.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 252.09M | 19.65% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 262.00M |
| Fennec Pharmaceuticals | 258.54M |
| Prelude Therapeutics | 257.08M |
| Palisade Bio | 257.03M |
| Inhibikase Therapeutics | 251.68M |
| Cibus | 244.55M |
| Alector | 241.69M |
| Nuvectis Pharma | 240.94M |